China Pharma (NYSE:CPHI) Now Covered by StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Saturday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

NYSE CPHI opened at $0.24 on Friday. China Pharma has a 52 week low of $0.13 and a 52 week high of $0.44. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a fifty day moving average of $0.22 and a two-hundred day moving average of $0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.